Terminal deoxynucleotidyltransferase in chronic myelogenous leukemia.
D000208:Acute Disease; D000328:Adult; D000818:Animals; D002417:Cattle; D002852:Chromatography, Ion Exchange; D004254:DNA Nucleotidyltransferases / Q000097:blood* / Q000302:isolation & purification; D003854:Deoxyribonucleotides; D005033:Ethylmaleimide / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D007951:Leukemia, Myeloid / Q000201:enzymology*; D007962:Leukocytes / Q000201:enzymology*; D008274:Magnesium / Q000494:pharmacology; D008297:Male; D008345:Manganese / Q000494:pharmacology; D008970:Molecular Weight; D009841:Oligonucleotides; D011119:Polynucleotides; D012293:Rifampin / Q000494:pharmacology; D013329:Structure-Activity Relationship; D013950:Thymus Gland / Q000201:enzymology; D014316:Tritium; D014461:Ultracentrifugation
D003854:Deoxyribonucleotides; D009841:Oligonucleotides; D011119:Polynucleotides; D014316:Tritium; D008345:Manganese; D004254:DNA Nucleotidyltransferases; D008274:Magnesium; D005033:Ethylmaleimide; D012293:Rifampin